BioCentury
ARTICLE | Clinical News

Tirosint levothyroxine: Postmarketing study started

August 18, 2014 7:00 AM UTC

Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label, U.S. postmarketing CONTROL trial to evaluate once-daily Tirosint in hypothyroid patients who have not previously achieved thyroid st...